Insider Trading activities of Molecular Insight Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Molecular Insight Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Molecular Insight Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Molecular Insight Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is MIPI. The reporting company's CIK number is 1340752.
The total value of stock buying since 2005 is $2,553,876.
The total value of stock sales since 2005 is $187,908.
The total value of stock option exercises since 2005 is $692,999.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Molecular Insight Pharmaceuticals, Inc. (MIPI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2011-01 0 $0 97,000 $16,031 0 $0
2010-12 0 $0 200,000 $40,900 0 $0
2010-01 0 $0 9,800 $19,844 0 $0
2009-12 0 $0 27,300 $63,700 0 $0
2009-05 4,000 $15,320 12,593 $47,433 0 $0
2008-12 0 $0 0 $0 81,249 $292,496
2008-03 0 $0 0 $0 12,500 $37,500
2007-11 38,906 $283,000 0 $0 79,168 $290,004
2007-06 0 $0 0 $0 8,333 $24,999
2007-03 25,250 $315,373 0 $0 0 $0
2007-02 142,150 $1,940,183 0 $0 80,000 $48,000

Table 2. Detailed insider stock purchases, sales, and option exercises of Molecular Insight Pharmaceuticals, Inc. insiders (MIPI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-01-28 Barlow David S (10% Owner) Sale 59,000 .16 9,381
2011-01-27 Barlow David S (10% Owner) Sale 38,000 .18 6,650
2010-12-17 Barlow David S (10% Owner) Sale 155,000 .20 31,000
2010-12-16 Barlow David S (10% Owner) Sale 45,000 .22 9,900
2010-01-14 Barlow David S (10% Owner) Sale 5,800 1.99 11,536
2010-01-12 Barlow David S (10% Owner) Sale 4,000 2.08 8,308
2009-12-24 Barlow David S (Director) Sale 2,000 2.34 4,680
2009-12-23 Barlow David S (Director) Sale 13,500 2.36 31,914
2009-12-21 Barlow David S (Director) Sale 6,300 2.33 14,704
2009-12-18 Barlow David S (Director) Sale 5,500 2.26 12,402
2009-05-29 Gottlieb Scott (Director) Buy 4,000 3.83 15,320
2009-05-28 Lafrance Norman D. (Sr. VP Clinical Dev and CMO) Sale 6,093 3.76 22,909
2009-05-22 Wallroth Donald E. (Chief Financial Officer) Sale 6,500 3.77 24,524
2008-12-29 Barlow David S (Director) Option Ex 81,249 3.60 292,496
2008-03-31 Hamermesh Joshua (VP Comm & Bus Development) Option Ex 4,166 3.00 12,498
2008-03-24 Hamermesh Joshua (VP Comm & Bus Development) Option Ex 8,334 3.00 25,002
2007-11-30 Lafrance Norman D. (Sr. VP Clinical Dev and CMO) Buy 2,000 8.76 17,530
2007-11-30 Babich John W (President/Chief Scientific Officer) Buy 2,500 8.34 20,862
2007-11-30 Barlow David S (Chief Executive Officer) Buy 5,000 8.47 42,355
2007-11-29 Lafrance Norman D. (Sr. VP Clinical Dev and CMO) Buy 2,000 8.00 16,000
2007-11-28 Frank Daniel (Director) Option Ex 4,167 4.80 20,001
2007-11-27 Kronauge James F (VP Process Development) Buy 7 6.50 45
2007-11-26 Kronauge James F (VP Process Development) Buy 2,399 6.50 15,593
2007-11-20 Babich John W (President/Chief Scientific Officer) Buy 10,000 6.90 69,050
2007-11-20 Barlow David S (Chief Executive Officer) Buy 15,000 6.77 101,565
2007-11-08 Barlow David S (Chief Executive Officer) Option Ex 75,001 3.60 270,003
2007-06-19 Hamermesh Joshua (VP Comm & Bus Development) Option Ex 8,333 3.00 24,999
2007-03-30 Feinberg Stephen (10% Owner) Buy 12,642 12.50 158,025
2007-03-29 Feinberg Stephen (10% Owner) Buy 7,409 12.50 92,605
2007-03-28 Feinberg Stephen (10% Owner) Buy 5,199 12.45 64,743
2007-02-28 Babich John W (President/Chief Scientific Officer) Option Ex 80,000 .60 48,000
2007-02-28 Feinberg Stephen (10% Owner) Buy 200 12.59 2,518
2007-02-23 Feinberg Stephen (10% Owner) Buy 1,754 12.50 21,925
2007-02-20 Feinberg Stephen (10% Owner) Buy 12,396 12.47 154,540
2007-02-16 Feinberg Stephen (10% Owner) Buy 10,400 12.50 130,000
2007-02-02 Feinberg Stephen (10% Owner) Buy 100,000 13.88 1,387,600
2007-02-01 Lamon Kim D (Director) Buy 3,000 14.00 42,000
2007-02-01 Sterling Lionel N (Director) Buy 14,400 14.00 201,600

Insider trading activities including stock purchases, stock sales, and option exercises of MIPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Molecular Insight Pharmaceuticals, Inc. (symbol MIPI, CIK number 1340752) see the Securities and Exchange Commission (SEC) website.